Albeit miR-125b has been demonstrated to be tumor suppressor in breast cancer by down-regulating ERBB2 and ERBB3 [22], several studies have showed its property to increase resistance of cancer cells, including breast cancer cells, to anticancer drug [37], resulting in subsequent recurrence and metastasis. Here, ERBB3 is linked to neoplasm.